FDA Chief Scientist Schwetz May Have Larger Role Under Henney
This article was originally published in The Gray Sheet
FDA Interim Chief Scientist and National Center for Toxicology Research Director Bernard Schwetz, PhD, may be in line for a more prominent role at FDA under Commissioner Jane Henney.
You may also be interested in...
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent appointee for the office vacated by Michael Friedman, MD.
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.